Appendix 2—table 43. Antidepressant Cohort (Region=New York State), Patient Characteristics Pre/Post Match.
| Region=NY by Antidepressant Use: Unmatched | Region=NY by Antidepressant Use: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | DEPR Non-users | DEPR Users | p-value | All | DEPR Non-users | DEPR Users | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 968,296 | 100.0% | 832,215 | 85.9% | 136,081 | 14.1% | 271,032 | 100.0% | 135,516 | 50.0% | 135,516 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 133,178 | 13.8% | 128,810 | 15.5% | 4,368 | 3.2% | <0.001 | 8,728 | 3.2% | 4,365 | 3.2% | 4,363 | 3.2% | 1.00 |
| 21-40 | 192,959 | 19.9% | 170,076 | 20.4% | 22,883 | 16.8% | 45,666 | 16.8% | 22,832 | 16.8% | 22,834 | 16.8% | ||
| 41-50 | 127,794 | 13.2% | 109,184 | 13.1% | 18,610 | 13.7% | 36,965 | 13.6% | 18,483 | 13.6% | 18,482 | 13.6% | ||
| 51-60 | 172,444 | 17.8% | 142,702 | 17.1% | 29,742 | 21.9% | 58,966 | 21.8% | 29,481 | 21.8% | 29,485 | 21.8% | ||
| 61-70 | 159,912 | 16.5% | 132,317 | 15.9% | 27,595 | 20.3% | 55,083 | 20.3% | 27,543 | 20.3% | 27,540 | 20.3% | ||
| 71-80 | 120,117 | 12.4% | 99,040 | 11.9% | 21,077 | 15.5% | 42,076 | 15.5% | 21,038 | 15.5% | 21,038 | 15.5% | ||
| ≥81 | 61,892 | 6.4% | 50,086 | 6.0% | 11,806 | 8.7% | 23,548 | 8.7% | 11,774 | 8.7% | 11,774 | 8.7% | ||
| Gender | ||||||||||||||
| Female | 573,610 | 59.2% | 476,684 | 57.3% | 96,926 | 71.2% | <0.001 | 192,930 | 71.2% | 96,468 | 71.2% | 96,462 | 71.2% | 0.98 |
| Male | 394,686 | 40.8% | 355,531 | 42.7% | 39,155 | 28.8% | 78,102 | 28.8% | 39,048 | 28.8% | 39,054 | 28.8% | ||
| Insurance | ||||||||||||||
| Commercial | 500,918 | 51.7% | 449,071 | 54.0% | 51,847 | 38.1% | <0.001 | 103,658 | 38.2% | 51,829 | 38.2% | 51,829 | 38.2% | 1.00 |
| Dual | 6,814 | 0.7% | 5,072 | 0.6% | 1,742 | 1.3% | 3,191 | 1.2% | 1,591 | 1.2% | 1,600 | 1.2% | ||
| Medicaid | 252,366 | 26.1% | 213,705 | 25.7% | 38,661 | 28.4% | 77,136 | 28.5% | 38,569 | 28.5% | 38,567 | 28.5% | ||
| Medicare | 208,198 | 21.5% | 164,367 | 19.8% | 43,831 | 32.2% | 87,047 | 32.1% | 43,527 | 32.1% | 43,520 | 32.1% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 521,282 | 53.8% | 467,739 | 56.2% | 53,543 | 39.3% | <0.001 | 106,797 | 39.4% | 53,397 | 39.4% | 53,400 | 39.4% | 0.99 |
| Yes | 447,014 | 46.2% | 364,476 | 43.8% | 82,538 | 60.7% | 164,235 | 60.6% | 82,119 | 60.6% | 82,116 | 60.6% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.65 | 1.39 | 0.59 | 1.32 | 0.98 | 1.71 | <0.001 | 0.96 | 1.68 | 0.96 | 1.68 | 0.96 | 1.68 | 0.99 |
CCI: Charlson Comorbidity Index; DEPR: antidepressant; PCP: primary care physician; SD: standard deviation.